Testing effectiveness (Phase 2)Study completedNCT01185028
What this trial is testing
A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures
Who this might be right for
Hepatitis C InfectionHIV Infection
National Institutes of Health Clinical Center (CC) 8